Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SI-BONE, Inc.SIBN · Entity 2501 | Director | April 15, 2019 | April 17, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SI-BONE, Inc.
Report date April 15, 2019 · Filed April 17, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 513,180 |
Reported balance
After 2019-04-15 transaction · row 1
1 source rowRow 1 · 2019-04-15 · Sale · Disposed 10,000 · Balance 513,180 F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $16.57 to $17.40, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 19,444 |
Reported balance
Holding disclosure · report date 2019-04-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 19,444 |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
F2: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $16.57 to $17.40, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 15, 2019 Filed Apr 17, 2019 23:46 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 10,000 | $16.95 | $169,459.00 |
DisclosureSEC source: 0001209191-19-025167 · doc4.xml · nonDerivative · entry 1 Reiley Mark A · CIK 0001754350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 513,180 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $16.57 to $17.40, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 19, 2018 Filed Oct 19, 2018 20:59 UTC | SI-BONE, Inc. SIBN · Entity 2501 | ConversionSeries 3 Preferred Stock · Derivative | 8,680 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-055706 · doc4.xml · derivative · entry 3 Reiley Mark A · CIK 0001754350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's Series 3 Preferred Stock automatically converted into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · price: The Issuer's Series 3 Preferred Stock automatically converted into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: The Issuer's Series 3 Preferred Stock automatically converted into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: The Issuer's Series 3 Preferred Stock automatically converted into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 19, 2018 Filed Oct 19, 2018 20:59 UTC | SI-BONE, Inc. SIBN · Entity 2501 | ConversionCommon Stock | 8,680 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-055706 · doc4.xml · nonDerivative · entry 1 Reiley Mark A · CIK 0001754350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's Series 3 Preferred Stock automatically converted into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.